EUVIMEDEUVIMED entdecken
Crossref

The mechanism of IL‐13 targeting IL‐13Rα2 in regulating oral mucosal FBs through PI3K/AKT/mTOR

Liping Wang iD, Jingyi Cheng, Junhui Huang, Ting Xiao, Zhangui Tang iD

Oral Diseases · 2024

DOI: 10.1111/odi.14760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Liping Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Academician Workstation for Oral-maxilofa…. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Interleukin-13, Proto-Oncogene Proteins c-akt, Mouth Mucosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this investigation was to examine the presence of interleukin (IL)‐13 and its receptor IL‐13Rα2 in the tissues of oral submucous fibrosis (OSF), investigate their biological functions, and explore the underlying mechanisms involved in the development of OSF. Materials and Methods The expression of IL‐13 and IL‐13Rα2 in the oral mucosa of patients with OSF and normal individuals was determined through immunohistochemistry and reverse transcription–quantitative polymerase chain reaction (RT–qPCR). Primary fibroblasts (FBs) were extracted through enzymatic digestion and then cultured. Immunofluorescence was employed to identify the FB cultures and the location of IL‐13Rα2. The effects of IL‐13/IL‐13Rα2/PI3K/AKT/mTOR on the migration, proliferation, and secretion of fiber‐related proteins of FBs were explored via the wound healing assay, CCK‐8 assay, EDU assay, and RT–qPCR. The impact of IL‐13Rα2 silencing and PI3K/AKT inhibition on the effect of IL‐13 on FBs was analyzed by RT–qPCR and Western blotting.

Results

IL‐13 and IL‐13Rα2 were highly expressed in OSF. Primary FBs were successfully extracted and cultured. IL‐13Rα2 was found to be localized in myofibroblasts. IL‐13 promoted the proliferation, migration, and secretion of fibril‐associated proteins in FBs. The proliferation, migration, and secretion of fibril‐associated proteins of FBs were decreased following IL‐13Rα2 silencing and inhibition of the PI3K/AKT/mTOR pathway.

Conclusion

IL‐13 may promote the proliferation, migration, and secretion of fiber‐related proteins of FBs through the PI3K/AKT/mTOR pathway by targeting IL‐13Rα2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesInterleukin-13Proto-Oncogene Proteins c-aktMouth MucosaPhosphatidylinositol 3-KinasesInterleukin-13 Receptor alpha2 SubunitFibroblastsCell MovementCell ProliferationOral Submucous FibrosisHumansSignal TransductionCells, CulturedMaleAdult

Stichwörter der Autor:innen

IL‐13IL‐13Rα2OSFPI3K/AKT/mTORfibroblastsphosphorylation

Substanzen

TOR Serine-Threonine KinasesInterleukin-13Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesInterleukin-13 Receptor alpha2 SubunitMTOR protein, humanIL13 protein, human

Autor:innen und Institutionen

  • Hunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Academician Workstation for Oral-maxilofacial and Regenerative Medicine & Hunan Clinical Research Center of Ora…

ORCID-Profile: Liping Wang, Zhangui Tang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, L., Cheng, J., Huang, J., Xiao, T., & Tang, Z. (2024). The mechanism of IL‐13 targeting IL‐13Rα2 in regulating oral mucosal FBs through PI3K/AKT/mTOR. Oral Diseases. https://doi.org/10.1111/odi.14760

Vancouver

Wang L, Cheng J, Huang J, Xiao T, Tang Z. The mechanism of IL‐13 targeting IL‐13Rα2 in regulating oral mucosal FBs through PI3K/AKT/mTOR. Oral Diseases. 2024. doi:10.1111/odi.14760

BibTeX
@article{Wang2024,
  author = {Wang, Liping and Cheng, Jingyi and Huang, Junhui and Xiao, Ting and Tang, Zhangui},
  title = {The mechanism of IL‐13 targeting IL‐13Rα2 in regulating oral mucosal FBs through PI3K/AKT/mTOR},
  journal = {Oral Diseases},
  year = {2024},
  doi = {10.1111/odi.14760}
}
Kostenlos starten →